| Document |
Document Title |
|
WO/2013/000778A1 |
The application relates to an applicator system (1) for applying a viscous liquid, in particular a transdermal pharmaceutical formulation, to the human skin comprising a metering dispenser (2) in turn comprising a container holding the v...
|
|
WO/2012/177626A1 |
A transdermal drug delivery system comprising a steroid as an active agent, wherein the steroid may be clobetasol propionate, betamethasone dipropionate, amcinonide, or loteprednol etabonate. The transdermal drug delivery system also com...
|
|
WO/2012/169884A1 |
The invention is directed to a method to discharge a fluid from a container, wherein the container comprises a reservoir for the fluid and an outlet opening for the fluid which outlet opening is fluidly connected to the reservoir by mean...
|
|
WO/2012/170417A2 |
Implantable medical devices and methods are provided that have one or more statins disposed therein. The medical devices may be implanted at near or in a bone defect to enhance bone growth. In some embodiments, the medical device provide...
|
|
WO/2012/170700A2 |
Described herein are applicators for delivery of a viscous material to a bone surface and methods of use. The applicator includes an elongate handle portion and a tip coupled to a distal location of the handle portion and formed of an el...
|
|
WO/2012/169736A2 |
The present invention relates to a patch for transdermal delivery of a composition and a manufacturing method thereof. According to the present invention, the patch includes a composition delivery layer which includes the compositions to...
|
|
WO/2012/165827A2 |
The present disclosure relates to a massage device provided with an ingredient for massaging supplied from a cover, and capable of performing a massage while discharging a certain quantity of a beautifying ingredient when needed. The mas...
|
|
WO/2012/162459A1 |
The present application describes devices and methods that use direct absorption to deliver mydriatic medications transclerally or transcorneally into the eye in order to enlarge the pupil of the eye of a patient. This may be done in pre...
|
|
WO/2012/156740A1 |
A skin priming device (10) for use in the management of psoriasis comprises a massaging head (12) having a plurality of projections (16) disposed on a massaging face (14) thereof; and a handle (20) extending from the rear of the massagin...
|
|
WO/2012/156715A1 |
The invention relates to improvements in apparatus and methods for producing ozone. The apparatus comprises : a differential pressure injector, a means for circulating aqueous fluid through the differential pressure injector and programm...
|
|
WO/2012/158935A1 |
An apparatus for producing medical foam for wound care or hair stimulation has a foam generation unit (12) including a fluid reservoir (290), a fluid delivery line (216) and a foam generation tip (280). The apparatus also includes a comp...
|
|
WO/2012/156716A1 |
The invention relates to improvements in surface disinfection apparatus and methods and in particular to apparatus and methods which may be used to disinfect wounds using high concentration aqueous ozone. The method comprises the steps o...
|
|
WO/2012/159026A1 |
The current invention discloses an indexable fluid dispenser suitable for ophthalmic treatments and delivering of ophthalmic agents such as eye drops. The fluid dispenser incorporates a tube made from compliant materials as the key dosin...
|
|
WO/2012/156687A1 |
The invention relates to improvements in surface disinfection apparatus and in particular to apparatus which may be used to disinfect wounds using high concentration aqueous ozone. The Apparatus comprises application means for applying t...
|
|
WO/2012/152612A1 |
Stick pack (10) for a liquid, cream or gel-type product comprising a tubular sachet (12) with a first end (14) and a second end (16); a first portion (13) close to the first end (14) being filled with liquid, cream or gel-type product; a...
|
|
WO/2012/149092A1 |
A combination therapy pad that includes a first layer and a second layer operatively coupled to the first layer. A fiber-optic array is disposed between the first layer and the second layer. A third layer is operatively coupled to the fi...
|
|
WO/2012/144437A1 |
The invention holds a prescribed amount of a drug solution and applies same to skin or mucosa without waste. The invention is equipped with a grip (10) for grasping, a neck part (12) that is continuous with the grip (10) and is elastical...
|
|
WO/2012/140250A1 |
Skin ventilation device (100) with a housing (5), which has three different inlet openings in order to ensure that various gaseous media needed for the function are able to enter the device in different ways. Since the device has an inbu...
|
|
WO/2012/131320A2 |
An applicator for topically applying a semi-solid medicament comprises an applicator head having an applicator face for spreading medicament across the skin; a sealable aperture on the applicator face; and a drive mechanism for forcing m...
|
|
WO/2012/135109A1 |
The present disclosure provides a new and improved intravitreal injection device, which is capable of locating the injection site with precision and reproducibility, ensuring the smooth delivery of medications or other treatments, and re...
|
|
WO/2012/125181A1 |
An eyedrop delivery system for the automated sequential dispensing of eyedrop solution from ampoules. The dispensing device includes an activation switch and visual and audible indicators to facilitate the dispensing action. The system i...
|
|
WO/2012/117302A2 |
A transdermal patch that can easily deliver a controlled volume of a fluidic drug compound to the skin is provided. More particularly, the patch contains a microneedle assembly that is configured to be placed in fluid communication with ...
|
|
WO/2012/119102A2 |
The present invention relates to compositions including a homeopathic aqueous substance active (HASA) and at least one hydrophilic gelling agent, the HASA comprises a homeopathic compound at a potency of 30C or higher and an uninhibited ...
|
|
WO/2012/113060A1 |
A stable delivery system for the therapeutic release and application of nitric oxide to a patient suffering from a cutaneous injury or wound includes a S-nitrosothiol and transition element nanoparticles. The transition metal nanoparticl...
|
|
WO/2012/112699A2 |
Systems and methods for delivering and infusing formulations containing riboflavin or its analogues, or other ophthalmic formulations, into corneal tissue are disclosed. Systems and methods are further disclosed to cross-link the corneal...
|
|
WO/2012/112836A1 |
A disposable sterile breakable vial includes a handle section and a vial section which are completely separable in response to a manually applied separation force. The vial section includes a sterile void dimensioned to contain a unit do...
|
|
WO/2012/100428A1 |
Disclosed is a medical air shower head structure, including a hollow bag body (1), an inlet duct (2) and a support (3). An air chamber (13) is formed within the hollow bag body (1). The hollow bag body (1) comprises an air discharging la...
|
|
WO/2012/103257A2 |
A transcutaneous multimodal delivery device for drug delivery and the methods of making and using the same are provided.
|
|
WO/2012/082659A1 |
An attachment for use with a unit dose eye drop dispenser comprises a tapered receptacle and a lateral positioning arm. The tapered receptacle is "squeezable" so that a reservoir of the unit dose dispenser can be placed within the recept...
|
|
WO/2012/078573A2 |
An applicator assembly may include body having a proximal end portion and a distal end portion, a container having a closed proximal end, an interior, and an open distal end, wherein the container is coupled to the proximal end portion, ...
|
|
WO/2012/063464A1 |
This tool (100) for applying a biological tissue adhesive has a nozzle body (1), a gas injection port (2), drug injection ports (3a, 3b), drug discharge ports (4a, 4b), drug ducts (5a, 5b), a gas discharge port (6), interconnecting ports...
|
|
WO/2012/061556A1 |
A drug delivery device is provided. The drug delivery device includes a drug reservoir in fluid communication with a microneedle array. The drug delivery device has a sliding actuation mechanism that may be activated by a button or lever...
|
|
WO/2012/058382A2 |
A device for delivering an active agent to target tissue at a site that includes a bodily fluid includes a body having a first exterior surface including a first section having a local, discrete recessed area formed in the body for holdi...
|
|
WO/2012/054878A2 |
An oral disposable apparatus to deliver a fluid, e.g., pharmacological agent to a patient in a one handed easy to use and sanitary manner. The apparatus includes a container capable of holding the fluid. The container is hermetically sea...
|
|
WO/2012/045135A1 |
UTENSIL FOR ASSISTING IN THE APPLICATION OF EYE DROPS, designed to facilitate the application of eye drops and other ophthalmic solutions or substances. The utensil (1) proposed herein comprises a basic monobloc structure (2), said basic...
|
|
WO/2012/044952A2 |
A drug delivery blade for delivering a drug depot to a treatment site in a patient is disclosed. The drug delivery blade includes a shaft defining a longitudinal axis of the blade, a lumen that extends longitudinally from a proximal end ...
|
|
WO/2012/036931A1 |
A device for stimulating the meibomian glands of the eyelid comprising: a handle; a head that is non-removable and integral to the handle, the head comprising an eyepiece that oscillates to provide a massaging action to an eyelid and tha...
|
|
WO/2012/031747A1 |
The invention relates to an application system for trans-epidermal surface administration of drugs, comprising a container (1) for receiving a sprayable composition containing an active compound, a propellant gas source (3) for a gas und...
|
|
WO/2012/025691A1 |
The invention relates to a fluid product dispensing head to be mounted onto an axial actuation rod (31) of a dispensing member (3). Said head includes an inner core (1) and an outer housing (2), the core (1) forming a connection sleeve (...
|
|
WO/2012/027025A2 |
A method for closing a sternum separated into at least a first sternum portion and a second sternum portion includes preparing at least one cut surface of at least one of the first or second sternum portions to have an adhesive applied t...
|
|
WO/2012/026829A1 |
A transdermal patch 10 containing one active ingredient, namely zingiber officinale rhizome (commonly known as 'ginger'), for the treatment of an inflammatory condition such as an is an arthritic condition. The transdermal patch includes...
|
|
WO/2012/021899A2 |
A system and method for determining an optimal combination drug product for a particular patient includes a processor that receives patient information and determines an optimal combination drug product based on the received information....
|
|
WO/2012/021801A2 |
The present invention generally relates to systems and methods for monitoring and/or providing feedback for drugs or other pharmaceuticals taken by a subject. In one aspect, the present invention is directed to devices and methods for de...
|
|
WO/2012/020416A2 |
A device for delivering an active agent to a tissue, comprising; a housing including a reservoir for containing said active agent; a delivery tip being in fluid communication with said reservoir; and, a delivery mechanism capable of deli...
|
|
WO/2012/019158A2 |
The present invention is directed to airless storage and dispensing systems that include a pump or dispensing package pre-filled with a topical semi-solid imiquimod pharmaceutical formulation ("pump systems") and methods for storing and ...
|
|
WO/2012/014986A1 |
Disclosed is a drug support body wherein it is possible to appropriately inject a drug to the anterior eye while reducing production costs. Specifically disclosed is a drug support body configured in a manner such that a drug layer (2) c...
|
|
WO/2012/012097A2 |
A medicine dispenser is provided. The dispenser includes a container having a spout on a first end thereof for dispensing a medicine and defining a generally elongate base on a second end thereof. The base has a width greater than a widt...
|
|
WO/2012/012333A1 |
Alpha-2 adrenergic agonists such as clonidine may be used to treat the pain associated with painful diabetic neuropathy (PDN) only in a subset of these patients. Targeted nociceptors (pain fibers) must be functionally expressed in the sk...
|
|
WO/2012/007730A1 |
An apparatus (100) for applying product to the skin of a person in a booth (10), comprising: an applicator (57) configured to apply the product to the person; a first guide (40) configured to guide movement of an applicator in a first di...
|
|
WO/2012/006677A1 |
Apparatus for applying a patch to a subject, the patch having a number of projections thereon, the apparatus including opposable jaws movable between open and engaging positions, wherein in the open position the jaws can receive at least...
|
